MARCOMIGNI, Luca
 Distribuzione geografica
Continente #
AS - Asia 49
NA - Nord America 45
EU - Europa 40
Totale 134
Nazione #
US - Stati Uniti d'America 45
VN - Vietnam 19
IE - Irlanda 18
HK - Hong Kong 12
SG - Singapore 10
IT - Italia 8
CN - Cina 6
FI - Finlandia 4
FR - Francia 3
RU - Federazione Russa 3
AT - Austria 1
DE - Germania 1
KR - Corea 1
NL - Olanda 1
UA - Ucraina 1
UZ - Uzbekistan 1
Totale 134
Città #
Dong Ket 19
Dublin 18
Hong Kong 12
Chandler 11
Singapore 7
San Mateo 5
Altamura 4
Beijing 3
Boardman 3
Lawrence 3
Medford 3
Princeton 3
Helsinki 2
Redwood City 2
Saint Petersburg 2
Wilmington 2
Amelia 1
Amsterdam 1
Aprilia 1
Frankfurt am Main 1
Guangzhou 1
Seoul 1
Vienna 1
Totale 106
Nome #
Alectinib's activity against CNS metastases from ALK-positive non-small cell lung cancer: a single institution case series 69
Targeting EGFR and ALK in NSCLC: current evidence and future perspective 37
Diagnosis and therapeutic management of parathyroid cancer, starting from the description of a clinical case 20
Repotrectinib’s Clinical Benefit and Its Brain Penetration in a Patient with Meningeal Carcinomatosis from G2032R-Mutated ROS-1 Positive Non-Small Cell Lung Cancer 9
Correction: Repotrectinib’s Clinical Benefit and Its Brain Penetration in a Patient with Meningeal Carcinomatosis from G2032R-Mutated ROS-1 Positive Non-Small Cell Lung Cancer (Oncology and Therapy, (2024), 12, 1, (163-171), 10.1007/s40487-023-00251-6) 5
Totale 140
Categoria #
all - tutte 787
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 787


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206 1 0 0 0 0 1 0 1 0 3 0 0
2020/202125 0 0 0 0 6 0 0 0 0 0 0 19
2021/202214 0 3 0 0 0 0 0 6 0 0 2 3
2022/202347 3 9 2 1 4 3 0 1 22 0 2 0
2023/202439 1 4 1 0 0 1 6 0 8 0 9 9
2024/20252 2 0 0 0 0 0 0 0 0 0 0 0
Totale 140